In situ phage screening. A method for identification of subnanogram tissue components in situ.
about
Phage display selection for cell-specific ligands: development of a screening procedure suitable for small tumor specimens.Ribosome display: next-generation display technologies for production of antibodies in vitro.A novel subtractive antibody phage display method to discover disease markers.Three-repeat Tau 69 is a major tau isoform in laser-microdissected Pick bodies.Towards a ligand targeted enzyme prodrug therapy: single round panning of a beta-lactamase scaffold library on human cancer cells.Selection of vimentin-specific antibodies from the HuCAL phage display library by subtractive panning on formalin-fixed, paraffin-embedded tissue.Developing bifunctional beta-lactamase molecules with built-in target-recognizing module for prodrug therapy: identification of Enterobacter Cloacae P99 cephalosporinase loops suitable for randomization and phage-display selection.Phage-display selection on tumor histological specimens with laser capture microdissection.Novel beta-lactamase-random peptide fusion libraries for phage display selection of cancer cell-targeting agents suitable for enzyme prodrug therapyBiopanning Phage-Display Libraries on Small Tissue Sections Captured by Laser Capture MicrodissectionSelection strategies for anticancer antibody discovery: searching off the beaten path.Hepatitis C virus NS4B targets lipid droplets through hydrophobic residues in the amphipathic helicesParadigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.Identification of keratinocyte-specific markers using phage display and mass spectrometry.Antibody Selection on FFPE Tissue Slides.Cys669-Cys713 disulfide bridge formation is a key to dystroglycan cleavage and subunit association.
P2860
Q33214333-62830421-7210-4ED0-B476-FB3295860EC5Q33218320-E50FD3D8-BCA2-45E2-A491-6DBD0D974BFFQ33226440-E385B0BB-83CE-401C-B80D-6DB76C25DC98Q33243165-5E0B5CB7-5A09-4B2C-803F-2ABBC555CABCQ33272567-912A4097-B9BA-4BBC-B524-868259723093Q33286935-C505700B-896A-4D35-B1B2-80FB2E753418Q33444939-BAD5B83B-912D-4531-80D9-9ED92684F1CFQ33470770-7E5B62C1-5BA3-4486-991C-01177A5F4CF9Q33502835-CCB57055-7CF7-4092-B34D-FC45FFD9D5DBQ33984770-3B92B69A-31E9-4569-8BE9-314D7203E0A1Q35589427-FD7C700C-417A-4D2A-A183-C409CF9DA0ABQ36709626-A663B738-67A6-4666-88CE-883EAB6059F9Q38910806-7D5DE39C-CC25-4C0A-AD75-57203A352018Q40663010-266A71FF-6E88-4DCE-8ADE-4D8A0E8FC610Q47425518-176CAE34-6CFB-41DA-9ABF-1E904C520DA3Q51800756-10B1C481-8AC1-44D5-8E14-EACCE63D1E5C
P2860
In situ phage screening. A method for identification of subnanogram tissue components in situ.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
In situ phage screening. A met ...... ram tissue components in situ.
@ast
In situ phage screening. A met ...... ram tissue components in situ.
@en
type
label
In situ phage screening. A met ...... ram tissue components in situ.
@ast
In situ phage screening. A met ...... ram tissue components in situ.
@en
prefLabel
In situ phage screening. A met ...... ram tissue components in situ.
@ast
In situ phage screening. A met ...... ram tissue components in situ.
@en
P2093
P2860
P356
P1476
In situ phage screening. A met ...... ram tissue components in situ.
@en
P2093
Chikashi Eguchi
Eriko Wakabayashi-Takai
Hiroyuki Toda
Kiyotoshi Kaneko
Masaru Furuta
Takashi Ito
Torahiko Tanaka
P2860
P304
30382-30387
P356
10.1074/JBC.M203547200
P407
P577
2002-06-04T00:00:00Z